Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients

Gaurav Agarwal, Mohammad Kazeroun, Mirian Salazar, Khrystal McBean, Lisa Ferguson, Jemma Larham, Jaimal Kothari, Naser Ansari-Pour, Sally Moore, Eileen Boyle, Udo Oppermann, Karthik Ramasamy, Angela Hamblin, Anjan Thakurta, Sarah Gooding

Blood (2023) 142 (Supplement 1): 644.

https://doi.org/10.1182/blood-2023-182734

Published: 2023

Journal Articles

High Throughput Risk-Adapted Monoclonal Gammopathy Community Monitoring Program

Gaurav Agarwal, Lauren Campbell, Oluremi Carty, Sally Moore, Sarah Gooding, Jaimal Kothari, Julia Evans, Jemma Larham, Lisa Ferguson, Pamela Roberts, Elizabeth Bateman, Ross Sadler, Karthik Ramasamy

Blood (2023) 142 (Supplement 1): 5077.

https://doi.org/10.1182/blood-2023-190444

Published: 2023

Journal Articles

Pembrowm: Results of a Multi-Centre Phase II Trial Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia

Jaimal Kothari, Toby A. Eyre, Ali Rismani, Helen McCarthy, Angela Collins, David John Lewis, Suzanne O Arulogun, William Wilson, Laura Clifton-Hadley, Darren Edwards, Kushani Ediriwickrema, Rebecca Auer, Guy Pratt, Ruth M. de Tute, Roger G Owen, Shirley D'Sa

Blood (2022) 140 (Supplement 1): 3624–3626.

https://doi.org/10.1182/blood-2022-167158

Published: 2022

Journal Articles

Ethnic Disparities in Waldenström's Macroglobulinaemia in the United Kingdom - Analysis from the Wmuk Rory Morrison Registry

Blood (2021) 138 (Supplement 1): 1977.

https://doi.org/10.1182/blood-2021-153590

Published: 2021

Journal Articles

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

Oliver Tomkins, BMBS, MRCP, Joshua Bomsztyk, Helen McCarthy, MBBS, PhD, Jaimal Kothari, Dima El-Sharkawi, Charalampia Kyriakou, Guy Pratt, Ali Rismani, MBBS, Shirley D'Sa

Blood (2019) 134 (Supplement_1): 4016.

https://doi.org/10.1182/blood-2019-129212

Published: 2019

Journal Articles

An Analysis from the WM UK Rory Morrison Registry - How Does Waldenström's Macroglobulinemia Affect Younger Patients?

Oliver Tomkins, BMBS, MRCP, Joshua Bomsztyk, Helen McCarthy, MBBS, PhD, Jaimal Kothari, Dima El-Sharkawi, Charalampia Kyriakou, Guy Pratt, Ali Rismani, MBBS, Shirley D'Sa

Blood (2019) 134 (Supplement_1): 1543.

https://doi.org/10.1182/blood-2019-123693

Published: 2019

Journal Articles

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

Stephen Booth, MA,MBBChir,MRCP,FRCPath, Hannah Plaschkes, Amy A Kirkwood, Adam Gibb, MBBS, Patrick Horgan, Joanna M Oladipo, Joseph Andrew Browning, DPhil,BMBCh, Usman Khan, John Willan, Julia Wolf, Arief Gunawan, MBBS, BSc, MRCP, Paul A Fields, MD PhD, Kim Linton, MBChB PhD, Claire Higham, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Jaimal Kothari, Catherine Hildyard, Toby A. Eyre

Blood (2019) 134 (Supplement_1): 1615.

https://doi.org/10.1182/blood-2019-127374

Published: 2019

Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD

Blood (2019) 134 (Supplement_1): 4768.

https://doi.org/10.1182/blood-2019-128139

Published: 2019

Journal Articles

Inferior Clinical Outcomes with Fixed Duration Therapy for Transplant Ineligible Myeloma Patients: UK Real-World Data in Comparison with First Trial (MM-020)

Faye A Sharpley, MBBChir, MA, MRCP, MSc BA, Faouzi Djebbari, MSc, Jaimal Kothari, John Lynes, Su McLain-Smith, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 3404.

https://doi.org/10.1182/blood.V130.Suppl_1.3404.3404

Published: 2017

Journal Articles

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Faye A Sharpley, MBBChir, MA, MRCP, MSc BA, Pedro Neffa, Fotis Panitsas, Jaimal Kothari, David Cutter, Roberta Shcolnik Szor, Manil Subesinghe, MBBS, MRCP, FRCR., Gracia Martinez, MD, Vanderson Rocha, MD PhD, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 5379.

https://doi.org/10.1182/blood.V130.Suppl_1.5379.5379

Published: 2017

Journal Articles

Age (≤75 years) and Not Choice of First-Line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset

Faouzi Djebbari, MSc, Faye A Sharpley, Connor Sweeney, Grant Vallance, Andy Peniket, Lisa Ferguson, Susan McLain-Smith, Jaimal Kothari, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 2154.

https://doi.org/10.1182/blood.V130.Suppl_1.2154.2154

Published: 2017

Journal Articles

"Real World" Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Combined Study from the Greek, Czech and UK Databases

Evangelos Terpos, MD PhD, Nadjoua Maouche, Jiri Minarik, MD PhD, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Eftathios Kastritis, Robin Aitchison, Meletios A. Dimopoulos, Karthik Ramasamy, Roman Hajek

Blood (2017) 130 (Supplement 1): 3087.

https://doi.org/10.1182/blood.V130.Suppl_1.3087.3087

Published: 2017

Journal Articles

Factors Influencing Outcomes of Relapse from Front-Line Autologous Stem Cell Transplant (ASCT) over a 14 Year Period: A Single Centre Experience

Selina J Chavda, MBBS BSc MRCP, Paul Michael Maciocia, BSc, MBBS, MRCP, Pavlina Mesiri, MSc, Nicholas Counsell, Jaimal Kothari, FRCPath, Antonia Bird, Ciaran Mariner, Anastasia Chew, MBBS, MRCP, FRCPATH, Katherine Clesham, MBBS, Sally Moore, BSc, FRPATH, FRCP, MBBS, Laura Percy, MBBS, MRCP, FRCPATH, Ali Rismani, MBBS, Shirley D'Sa, Rakesh Popat, Neil Rabin, Kwee L Yong

Blood (2016) 128 (22): 3465.

https://doi.org/10.1182/blood.V128.22.3465.3465

Published: 2016

Journal Articles

Excess Late Gastrointestinal Toxicity Associated with Leam Conditioning Compared to BEAM for Autologous Stem Cell Transplantation in Lymphoma, a Single Institution Experience

Jaimal Kothari, FRCPath, Michael Foley, MBBS, Karl S Peggs, Kirsty Thomson, Emma Morris, FRCPath, Kirit M Ardeshna, MD FRCPath, Andres E. Virchis, FRCPath, David C Linch, FMedSci, Jonathan Lambert, FRCPath

Blood (2014) 124 (21): 5898.

https://doi.org/10.1182/blood.V124.21.5898.5898

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure

Jaimal Kothari, MD, Antonia Ljubic, BSc, Karl S Peggs, MD, Kirsty Thomson, MD, Emma Morris, MD, Andres E. Virchis, MD, Jonathan Lambert, MD, Anthony H Goldstone, MD, David C Linch, MD FMedSci, Kirit M Ardeshna, MD

Blood (2011) 118 (21): 2025.

https://doi.org/10.1182/blood.V118.21.2025.2025

Published: 2011

Journal Articles

A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20 + Malignant Disease.

Laurie H. Sehn, MD, MPH, Sarit E. Assouline, MD, Douglas A. Stewart, MD, Joy Mangel, MD, FRCPC, Pavel Pisa, MD, PhD, Jaimal Kothari, MD, Michael Crump, MD

Blood (2009) 114 (22): 934.

https://doi.org/10.1182/blood.V114.22.934.934

Published: 2009

Journal Articles

Low Dose Prothrombin Complex Concentrates Reverse Oral Anticoagulation with Minimal Complications.

Catherine N. Bagot, MBBS, MD, MRCP, Jaimal Kothari, MBBS, MRCP, Raj K. Patel, MD, MRCP, MRCPath, Roopen Arya, PhD, FRCP, FRCPath

Blood (2006) 108 (11): 891.

https://doi.org/10.1182/blood.V108.11.891.891

Published: 2006

NARROW

Targeted NGS Panel Guides Risk-Adapted Treatment Intention in Newly Diagnosed Myeloma Patients

High Throughput Risk-Adapted Monoclonal Gammopathy Community Monitoring Program

Pembrowm: Results of a Multi-Centre Phase II Trial Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia

Ethnic Disparities in Waldenström's Macroglobulinaemia in the United Kingdom - Analysis from the Wmuk Rory Morrison Registry

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

An Analysis from the WM UK Rory Morrison Registry - How Does Waldenström's Macroglobulinemia Affect Younger Patients?

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Inferior Clinical Outcomes with Fixed Duration Therapy for Transplant Ineligible Myeloma Patients: UK Real-World Data in Comparison with First Trial (MM-020)

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Age (≤75 years) and Not Choice of First-Line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset

"Real World" Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Combined Study from the Greek, Czech and UK Databases

Factors Influencing Outcomes of Relapse from Front-Line Autologous Stem Cell Transplant (ASCT) over a 14 Year Period: A Single Centre Experience

Excess Late Gastrointestinal Toxicity Associated with Leam Conditioning Compared to BEAM for Autologous Stem Cell Transplantation in Lymphoma, a Single Institution Experience

Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure

A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20 + Malignant Disease.

Low Dose Prothrombin Complex Concentrates Reverse Oral Anticoagulation with Minimal Complications.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only